# PROGNOSTIC IMPACT OF CTDNA IN 1L DLBCL 


This is additional exploratory work done with publicly available data from:



[_Tabari, Ehsan et al._ NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL. _Leukemia & lymphoma vol. 65,5 (2024): 618-628. doi:10.1080/10428194.2024.2301924_](https://doi.org/10.1080/10428194.2024.2301924)


A copy of the paper is available for download at [ehsantabari.com/public/goya_paper](https://ehsantabari.com/public/goya_paper)
